Instanosis enables rapid and portable detection and quantitation of extremely low concentrations of biomarkers across many diseases. Our first-of-its-kind technology platforms are hundreds of times more sensitive than state-of-the-art, at much lower cost, leading to accurate and instantly actionable results and cost savings for research, clinical trials, disease diagnosis and monitoring.